Exploratory comparisons between different anti-mitotics in clinically-used drug combination in triple negative breast cancer
Triple-negative breast cancer (TNBC) constitutes a very aggressive type of breast cancer with few options of cytotoxic chemotherapy available for them. A chemotherapy regimen comprising of doxorubicin hydrochloride and cyclophosphamide, followed by paclitaxel, known as AC-T, is approved for usage as...
| Main Authors: | Guido, Bruna Cândido, Brandão, Douglas Cardoso, Barbosa, Ana Luisa Augusto, Vianna, Monique Jacob Xavier, Faro, Lucas, Ramos, Luciana Machado, Nihi, Fabíola, Castro, Márcio Botelho de, Neto, Brenno A. D., Corrêa, José Raimundo, Báo, Sônia Nair |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Oncotarget
2021
|
| Subjects: | |
| Online Access: |
https://repositorio.unb.br/handle/10482/42548 https://doi.org/10.18632/oncotarget.28068 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!